| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/02/2006 | EP1685832A1 Nerve regeneration promoters |
| 08/02/2006 | EP1685152A2 Il-18 binding proteins |
| 08/02/2006 | EP1685142A1 Phosphinic acid derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/02/2006 | EP1685115A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 08/02/2006 | EP1685105A1 Allosteric modulators of metabotropic glutamate receptors |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1684806A1 Compositions and methods of treatment using l-type calcium channel blockers and cholinesterase inhibitors |
| 08/02/2006 | EP1684775A1 Use of extracts from the pelargonium species |
| 08/02/2006 | EP1684766A1 USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR TH E MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| 08/02/2006 | EP1684765A1 Use of (2s, 3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol |
| 08/02/2006 | EP1684761A1 Method and composition for treatment or prophylaxis of amyloidosis disorders |
| 08/02/2006 | EP1684755A1 Use of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders |
| 08/02/2006 | EP1684751A1 Use of 1-thia-dibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/02/2006 | EP1684749A1 USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 08/02/2006 | EP1684746A1 USE OF 1-AZA-DIBENZO[e,h]|AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/02/2006 | EP1684742A1 Use of 1-oxadibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/02/2006 | EP1684737A1 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 08/02/2006 | EP1684702A2 Use of 2-thia-dibenzo(e,h) azulenes for the treatment and prevention of central nervous system diseaes and disorders |
| 08/02/2006 | EP1578416B1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles |
| 08/02/2006 | EP1556045B1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 08/02/2006 | EP1532147B1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 08/02/2006 | EP1450843B1 Use of thymulin-like peptides for making pain-relieving medicines |
| 08/02/2006 | EP1435971B1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1325003B1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino 4,5-b|quinoline-1,10-dione and the use thereof for the treatment of pain |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 08/02/2006 | EP0862428B1 Ginkgolides for inhibition of membrane expression |
| 08/02/2006 | CN1812984A Benzofuranyl-and benzothienyl-piperazinyl quinolines as 5-serotonin reuptake inhibitors |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812800A Muscle derived cells(mdc) for promoting and enhancing nerve repair and regeneration |
| 08/02/2006 | CN1812791A Methods of preventing and reducing the severity of stress-associated conditions |
| 08/02/2006 | CN1812786A Use of pyrazolopyridines for the treatment of cognitive deficits |
| 08/02/2006 | CN1812778A Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
| 08/02/2006 | CN1810960A Method of inducing differentiation of human amnion mesenchyme stem cell to nerve cell |
| 08/02/2006 | CN1810828A Fatty acid-carnosine composite and its prepn |
| 08/02/2006 | CN1810289A Compounding process of scorpion medicine wine |
| 08/02/2006 | CN1810284A Yunnan Rhizoma Paridis extract and its prepn, medicinal use and medicine composition |
| 08/02/2006 | CN1810274A Cassia, its extract cinnamal and their application in preparing medicine for treating depression |
| 08/02/2006 | CN1810257A Oral liquid of Huonaosu |
| 08/02/2006 | CN1810255A Orally taken health article for treating senile dementia |
| 08/02/2006 | CN1810252A New pharmaceutical use of echinacoside |
| 08/02/2006 | CN1810242A Slow-released vincamine capsule and its prepn process |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/02/2006 | CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267427C Process for production of citalopram |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267123C Chinese medicine composition with drug-dropping action, and its preparing method and quality control method |
| 08/02/2006 | CN1267108C Medication for treating painful symptoms of the illness |
| 08/02/2006 | CN1267107C Extraction method of scorpion active protein liquid |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267094C Orally disintegrating tablet of safflor yellow and its preparation process |
| 08/02/2006 | CN1267092C Orally administered Modafinil medicine compostion |
| 08/02/2006 | CN1267089C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
| 08/02/2006 | CN1267016C Composition and method |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084170 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 08/01/2006 | US7084169 Aminoalkoxyindoles and methods of use |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084152 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084120 Prodrugs of DP IV-inhibitors |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |